Jiangxi Province Cancer Hospital

Nanchang

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Peripheral T Cell Lymphoma

Studies at this site

• Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8) — Completed